Untitled Document
www.expresshealthcare.in INSIGHT INTO THE BUSINESS OF HEALTHCARE
January 2009  
Untitled Document
Sections

Market
50 Pathfinders
Wellness & Preventive Care
Value Add

Services
Subscribe/Renew
Archives/Search
Contact Us
Network Sites
Express Computer
Exp. Channel Business
Express Hospitality
Express TravelWorld
Express Pharma
Group Sites
ExpressIndia
Indian Express
Financial Express

Home - Market - Article

Launch

Cryo-Save Group Comes to India

It has been set up in Bangalore with an investment of 1.8 Million Euros

Cryo-Save Group has announced the launch of its India operations through its 100 per cent subsidiary— Cryo-Save India. The Indian subsidiary has been set up with an investment of 1.8 Million Euros. Cryo-Save Group will scale up its investment to two million Euros within a year of its operation of the Indian subsidiary. Cryo-Save Group, Europe's largest adult stem cell storage bank, has its operations in 37 countries across three continents. Cryo-Save India brings to the table a depth of expertise and experience in stem cell banking.

Cryo-Save India will be the only company in India with its offering of dual-storage system and this will be available for the first time in the country. They are also said to be the only company that does automatic processing to avoid manual intervention and contamination. The company will be offering the collection and storage of adult stem cells derived from cord blood. The services will be available across all metros and other cities.

Said VR Chandramouli, Managing Director, Cryo-Save India, "We are very keen to extend our footprints to India as we are very excited about the immense market potential for adult stem cell banking in India. The launch of the Indian operations will mark a new chapter in the quality of stem cell banking services offered. Cryo-Save India will bring in our global expertise, best practices and our vast experience to the Indian customer."

In the last 18 years, more than 10,000 patients have been treated with cord blood stem cells transplantations in over 150 countries. Umbilical cord blood stem cells have been used over the years in an increasing number of treatments including leukemia, myelodysplastic syndrome, lymphomas, red cell disorders and more. Currently, stem cell research is being done for more than 85 diseases.

"We see a huge potential in the stem cell banking business in India and we have set up the best-in-class facility with an investment of nearly 1.8 million Euros to cater to this huge need which is set to grow manifold," he further added. Cryo-Save India is headquartered in Bangalore with a fully automated adult stem cell storage facility. The facility at Bangalore covers 10,000 sq ft with a storage capacity of 150,000 samples, extendable to 300,000 immediately.

EH News Bureau

 


Untitled Document
© Copyright 2001: The Indian Express Limited. All rights reserved throughout the world. This entire site is compiled in Mumbai by the Business Publications Division (BPD) of The Indian Express Limited. Site managed by BPD.